M&A led growth strategy to build a differentiated, full-spectrum IVD business

Avacta’s Diagnostics division is actively pursuing an M&A led growth strategy with a vision to build a full spectrum IVD business supporting healthcare professionals to diagnose disease and broadening access to diagnostics to enhance health, fitness and well-being.

Our M&A strategy is focused on the highest value parts of the diagnostics  sector –  innovative product development and the commercial routes to market in both the centralised hospital laboratory and decentralised healthcare markets.

In the highly competitive diagnostics market, Avacta’s proprietary Affimer® platform provides a powerful tool to differentiate our immunodiagnostic products to gain competitive advantage and grow the market share of acquired businesses.

Contact Us

Get in touch with us if you have a commercial enquiry.

Read More

Our brands

Discover the brands within the Avacta Diagnostics Group.



Meet the Diagnostics senior leadership team.

Meet the team